Outsourcing STREAM

  1. Thermo Fisher Scientific China Single-Use Technologies Capacity Expansion 3/2/2021

    Thermo Fisher Scientific is expanding our single-use manufacturing network globally. With continuous growth in China’s population, we have seen an increase in demand for human therapeutics and vaccines and an even greater need for investment in public health and safety to develop biopharmaceutical products in China.

  2. Explore The M Lab Collaboration Center In Burlington MA 9/19/2022

    Our global network of scientific experts, innovative technologies, and non-GMP facilities, empower drug developers of all sizes to achieve manufacturing excellence and innovation through collaborative exploration and learning. Explore 1 of our 8 global facilities today.

  3. Biopharma Resilience: Bionova Scientific Talks Capacity, Speed, And Agility 10/7/2022

    Bionova Scientific shares how a CDMO can offer biopharma companies the flexible capacity they need to meet the growing needs for medicines today and in the future.

  4. Raman PAT Platform – Model Building Support Animation 11/16/2021

    Interested in implementing Raman as a PAT tool to monitor your bioprocesses in-line and in real time? But not a chemometric expert? Our experts are here to support you! Watch this video to learn more.

  5. The Journey To Safety Through Viral Clearance 12/1/2022

    Discover a simple yet powerful solution for getting viral clearance studies done safely, thoroughly, efficiently, and on your timelines. Learn how to free your teams and trust your project.

  6. Commercial Readiness with Orca Bio's Dan Kirby 9/14/2023

    Orca Bio's Dan Kirby has played a hand in prepping more than a few approved biologic therapeutic candidates for commercialization. Equally important, he knows firsthand what makes or breaks post-approval commercial efforts, having played virtually every role there is to play in drug sales and marketing.

  7. Increasing The Reach Of Cell And Gene Therapies 4/29/2021

    The cell and gene therapy industry is rapidly evolving from the perspective of “can we commercialize this class of therapeutics?” to “how do we reach patients who need these therapies?”. However, the promise of these biologics can only be realized if the industry approaches manufacturing parity with monoclonal antibodies. A mixture of innovation and brute-force streamlining is needed to create viable cell and gene therapy templates. In this video, we discuss how upstream process optimization is ripe for innovative approaches.

  8. A Dedicated Team To Safely Store Your Cell And Virus Banks 2/27/2023

    The safety of your cell and virus banks must be your top priority. Learn about a team dedicated to the safety of your material along with their related services.

  9. Selecting The Right CMO For Your Gene Therapy 5/15/2020

    Find out what criteria makes a great CMO partner and how to know if it is the right one for your gene therapy.

  10. How MilliporeSigma Promotes Quality And Risk Reduction 10/20/2021

    Learn how MilliporeSigma’s new facility was built with quality and risk reduction at the top of mind and its experts have the experience to support large-scale programs through commercialization.